Pulmonx (Lung) 2025 Earnings Outlook for Investors
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Compare index funds with the lowest expense ratios for retirement in 2024 to minimize fees while pursuing solid returns. Find your top pick today.
27,341 articlesPulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
This deep dive breaks down NCDLs Q1 2026 performance, translates what the ncdl 2026 earnings call hinted at, and show...
NCS Multistage's Q4 2025 earnings call offers insight into margins, backlog, and growth drivers. This guide translate...
Costco reports a strong surge in online demand alongside record gas volume, but the stock still slid. This analysis e...
As cyber threats rise, sentinelOne's 2026 earnings call will reveal how the company plans to expand its AI-driven pla...
SpaceX's public debut ignites a rapid sector rotation out of listed space stocks. Virgin Galactic craters 24% as inve...
When housing activity ebbs, flooring companies face a turning point. This article explores how a leading flooring com...
Rivian shocks investors by cutting jobs shortly after starting to deliver the R2. This move raises questions about ho...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...